-

GN Corporation’s academic event NCRM NICHE commemorates 21st anniversary of NCRM.

Kamineni Institute, Hyderabad wins XXI Fujio Cup Quiz on stem cells and regenerative medicine.

KOFU, Japan--(BUSINESS WIRE)--The XXI edition of Fujio Cup Quiz (FCQ) in NCRM NICHE 2026, hosted by GN Corporation, Japan and Nichi-In centre for Regenerative Medicine (NCRM), was won by Sameer Kumar Reddy and Chava Aravind Kumar from Kamineni Academy of Medical Sciences and Research Centre, Hyderabad, India. Ganga Anand Desai and Amith Mathew from Sri Ramachandra Institute of Higher Education and Research, Chennai, India, came runners.

GNCorp’s academic contribution spearheading several discoveries and healthcare solutions in regenerative medicine, commemorating the 21st anniversary NCRM NICHE and Fujio Cup Quiz. XXI FCQ stem cell quiz was won by Kamineni Institute, Hyderabad, India.

Share

International regenerative medicine event, NCRM NICHE, hosted by GNCorp continuously for the past 21 years, in academic partnership with German Society of Stem Cell research (GSZ) and Training program in Regenerative Medicine (TPRM), University of Toronto, to our knowledge, has the world’s one and only active knowledge-gaining (AKG) event, FCQ, alongside passive knowledge-gaining (PKG) plenary lectures and interdisciplinary conclave (IDC), with following features:

NCRM NICHE initiated collaborations have helped GNCorp develop and propagate many healthcare care solutions:

GNCorp is open for collaborating with likeminded institutes to co-host, NCRM NICHE, FCQ and partner with JSRM.

Contacts

Samuel JK Abraham, info@gncorporation.com

More News From GN Corporation Co Ltd

Pioneering feat in regenerative medicine, the BEES-HAUS cell therapy: Paracrine effect and cell engraftment, together healing urethral stricture. Its simplified version, BHES-HAUS’ results to be presented in AUA 2026

TOKYO--(BUSINESS WIRE)--A path breaking scientific discovery, unraveling successful wound healing mechanism in urethral stricture with BEES-HAUS cell therapy has been reported by Indo-Japan physician-scientists. This milestone achievement in regenerative medicine, yielding clinical safety and efficacy, is the first of its kind, wherein a hybrid approach of mixing two groups of autologous buccal epithelial cells, one cultured in 2D and another in 3D in Festigel scaffold were used in the manageme...

Colorectal, Liver, and Lung Cancer Patients at Vinmec Experience Extended Survival with AIET Cell-Based Immunotherapy – Technology Transferred from Japan

TOKYO--(BUSINESS WIRE)--AIET cell therapy prolongs survival of cancer patients in Vinmec Hospital, Vietnam, with tech-transfer by GN Corporation & NCRM; soon in Mauritius...

Cell therapy for male urethral stricture: BEES-HAUS clinical application in Edogawa Hospital Japan, reports Dr. Akio Horiguchi in IMORU.

TOKYO--(BUSINESS WIRE)--Urethral stricture affecting men of all ages, with increasing incidence after 55, is a recurring problem despite several treatment options. By transplanting autologous lab-engineered buccal tissue cells (BEES-HAUS), Dr Akio Horiguchi successfully accomplished the first clinical transplantation in Edogawa Hospital, Japan as per Japanese Regenerative Medicine law, and presented in International Meeting Of Reconstructive Urology (IMORU) in Hamburg, Germany. Safety and effic...
Back to Newsroom